2025
SJR Q1
JCR Q2 · 3,4
OA
12 eşleşen makale
SCIE
Dergi ayrıntısı
Infection and Immunity
- Yayıncı
- American Society for Microbiology
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0019956710985522
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,171
- Quartile Q1
- H-Index 257
- Atıf/yayın 3,28
- Doküman (3y) 528
- Atıf (3y) 1.778
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,4
- 5Y JIF 3,7
- JCI 0,74
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Immunology Q2
- Infectious Diseases Q1
- Microbiology Q2
- Parasitology Q1
Alanlar
- Immunology and Microbiology
- Medicine
WoS kategorileri
- Immunology | Infectious Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,171 | 3,4 | 3,7 | 0,74 | Q2 | 257 |
| 2024 | Q1 | Q2 | 1,054 | 2,8 | 3,1 | 0,67 | Q3 | 249 |
| 2023 | Q1 | Q2 | 1,042 | 2,9 | 3,1 | 0,56 | Q3 | 249 |
| 2022 | Q1 | Q3 | 0,923 | 3,1 | 3,2 | 0,62 | Q2 | 249 |
| 2021 | Q1 | Q3 | 1,139 | 3,6 | 3,9 | 0,74 | Q2 | 249 |
| 2020 | Q1 | Q3 | 1,508 | 3,4 | 3,7 | 0,9 | Q2 | 249 |
| 2019 | Q1 | Q2 | 1,581 | 3,2 | 3,4 | 0,92 | Q2 | 249 |
| 2018 | — | Q2 | — | 3,2 | 3,5 | 0,97 | Q2 | — |
| 2017 | Q1 | Q2 | 1,954 | 3,3 | 3,6 | 1,03 | Q2 | 249 |
| 2016 | Q1 | Q2 | 2,04 | 3,6 | 3,8 | — | — | 249 |
| 2015 | Q1 | Q1 | 2,361 | 3,6 | 3,8 | — | — | 249 |
| 2014 | Q1 | Q2 | 2,344 | 3,7 | 3,9 | — | — | 249 |
| 2013 | Q1 | Q1 | 2,433 | 4,2 | 4,1 | — | — | 249 |
| 2012 | Q1 | Q1 | 2,386 | 4,1 | 4,1 | — | — | 249 |
| 2011 | Q1 | Q1 | 2,298 | 4,2 | 4,1 | — | — | 249 |
| 2010 | Q1 | Q1 | 2,301 | 4,1 | 4,1 | — | — | 249 |
| 2009 | — | Q1 | — | 4,2 | 4,2 | — | — | — |
| 2008 | — | Q1 | — | 4 | 3,9 | — | — | — |
| 2007 | — | Q1 | — | 4 | 4 | — | — | — |
| 2006 | — | Q1 | — | 4 | — | — | — | — |
| 2005 | — | Q1 | — | 3,9 | — | — | — | — |
| 2004 | — | Q1 | — | 4 | — | — | — | — |
| 2003 | — | Q1 | — | 3,9 | — | — | — | — |
| 2002 | — | Q1 | — | 4 | — | — | — | — |
| 2001 | — | Q1 | — | 4,2 | — | — | — | — |
| 2000 | — | Q1 | — | 4,2 | — | — | — | — |
| 1999 | — | Q1 | — | 4,2 | — | — | — | — |
| 1998 | — | Q1 | — | 4 | — | — | — | — |
| 1997 | — | Q1 | — | 3,7 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q2 | 93/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 49/141 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 107/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q2 | Q3 | 57/137 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q2 | Q3 | 58/132 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q3 | 118/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 62/96 |
| 2021 | IMMUNOLOGY | SCIE | Q3 | Q2 | 112/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 62/95 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q2 | 107/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 48/93 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q2 | 87/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 39/92 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q2 | 80/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 34/89 |
| 2017 | IMMUNOLOGY | SCIE | Q2 | Q2 | 75/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 30/88 |
| 2016 | IMMUNOLOGY | SCIE | Q2 | — | 57/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q2 | — | 23/84 |
| 2015 | IMMUNOLOGY | SCIE | Q2 | — | 56/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q1 | — | 20/83 |
| 2014 | IMMUNOLOGY | SCIE | Q2 | — | 47/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q2 | — | 23/78 |
| 2013 | IMMUNOLOGY | SCIE | Q2 | — | 38/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q1 | — | 14/72 |
| 2012 | IMMUNOLOGY | SCIE | Q2 | — | 35/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q1 | — | 14/70 |
| 2011 | IMMUNOLOGY | SCIE | Q1 | — | 33/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q1 | — | 12/70 |
| 2010 | IMMUNOLOGY | SCIE | Q1 | — | 33/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q1 | — | 11/58 |
| 2009 | IMMUNOLOGY | SCIE | Q1 | — | 27/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/57 |
| 2008 | IMMUNOLOGY | SCIE | Q1 | — | 27/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/51 |
| 2007 | IMMUNOLOGY | SCIE | Q1 | — | 28/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/50 |
| 2006 | IMMUNOLOGY | SCIE | Q1 | — | 27/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/47 |
| 2005 | IMMUNOLOGY | SCIE | Q1 | — | 22/115 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/43 |
| 2004 | IMMUNOLOGY | SCIE | Q1 | — | 19/111 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/41 |
| 2003 | IMMUNOLOGY | SCIE | Q1 | — | 21/114 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q1 | — | 6/41 |
| 2002 | IMMUNOLOGY | SCIE | Q1 | — | 21/119 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q1 | — | 6/38 |
| 2001 | IMMUNOLOGY | SCIE | Q1 | — | 17/114 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q1 | — | 5/37 |
| 2000 | IMMUNOLOGY | SCIE | Q1 | — | 15/116 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q1 | — | 5/36 |
| 1999 | IMMUNOLOGY | SCIE | Q1 | — | 15/115 |
| 1999 | INFECTIOUS DISEASES | SCIE | Q1 | — | 4/35 |
| 1998 | IMMUNOLOGY | SCIE | Q1 | — | 16/120 |
| 1998 | INFECTIOUS DISEASES | SCIE | Q1 | — | 5/36 |
| 1997 | IMMUNOLOGY | SCIE | Q1 | — | 15/117 |
| 1997 | INFECTIOUS DISEASES | SCIE | Q1 | — | 3/34 |